Navigation Links
Sinovac Reports Unaudited First Quarter 2011 Financial Results
Date:5/13/2011

5 - research and development expenditures qualified for   government grant(73,390)(17,554) - depreciation of property, plant and equipment   and amortization of licenses and permits1,192,706891,007 - deferred government grant recognized in income (68,482)(65,830)- accretion expense101,845-Changes in: - accounts receivable46,5771,829,731 - inventories(2,281,688)(3,771,749) - income tax payable (refundable) (103,393)(2,628,408) - prepaid expenses and deposits(9,231)(335,770)- deferred revenue and advances from customers(302,680)(234,054) - accounts payable and accrued liabilities(2,878,114)(6,100,581)Net cash used in operating activities(7,689,736)(10,146,421)Cash flows from (used in) financing activities- Loan proceeds-8,265,031- Proceeds from issuance of common stock,   net of share issuance costs284,70961,867,706- Dividends paid to non-controlling shareholder of Sinovac Beijing(2,456,884)-- Government grant received -46,811- Loan to non-controlling shareholder of  Sinovac  Beijing -(6,572,159)Net cash provided by  (used in) financing activities(2,172,175)63,607,389Cash flows used in investing activities - Proceeds from disposal of equipment-189,876-  Proceeds from redemption of short-term investments-7,314,187-  Purchase of short-term investments-(8,338,173) - Deposits for acquisition of equipment(1,529)(8,265,031) - Acquisition of property, plant and equipment(1,153,348)(448,165)Net cash used in investing activities(1,154,877)(9,489,345)Exchange gain on cash and cash equivalents407,5997,630Increase in cash and cash equivalents(10,609,191)43,979,253Cash and cash equivalents, beginning of period101,585,49074,953,212Cash and cash equivalents, end of period$

90,976,299

$

118,932,465Cash paid for interest$

103,393

$

268,279Cash paid for income taxes$

306,017

$

1,653,353Supplemental schedule of non-cash activities:  Acquisition of property, plant and equipment in
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sinovac Presents at Two Investor Conferences in May 2011
2. Sinovac Files Annual Report on Form 20-F
3. Sinovac Participates in UBS Greater China Healthcare Corporate Day
4. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
5. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
6. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
7. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
8. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
9. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
10. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
11. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014 Statistics released ... and drunk driving increase astronomically during the holidays, beginning ... in many cities. The data, ... Monitoring Systems as part of their annual ... paints a picture of high-risk drinking and increased rates ...
(Date:11/21/2014)...  Alere Inc. (NYSE: ALR ), a ... Juliet Cunningham as Vice President, Investor Relations. In ... driving communications with the investment community. "As ... to increase shareholder value, it is critical that we ... Chief Executive Officer. "We are delighted that Juliet ...
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek Pharmaceuticals, ... the Company is scheduled to present at the Biotech ... CA on January 12-14, 2015. ... CEO of Rock Creek Pharmaceuticals, will present preclinical and ... agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan will ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... Aug. 4, 2011 It,s back-to-school season and for ... head lice. To view the multimedia assets ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM45457 ) ... in the U.S. are infested with this common, six-legged ...
... HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com ... in Alabama, Florida, and Mississippi, announced today that ... has personally guaranteed the financing that was used ... http://finance.yahoo.com/news/HASCO-Medical-Announces-prnews-1072922352.html?x=0&.v=1 on May 17th, 2011. ...
Cached Medicine Technology:Head Lice Returns to School: Five Tips to Avoid Panic and Worry 2HASCO Medical Chairman Provides $2 Million in Capital and a Personal Guarantee on Additional $2 Million Promissory Note 2HASCO Medical Chairman Provides $2 Million in Capital and a Personal Guarantee on Additional $2 Million Promissory Note 3
(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... Eugene, OR (PRWEB) November 22, 2014 The ... addition of Roy Baroff to its team of ... lawyer, mediator, soccer player, coach, and referee. He has over ... North Carolina and beyond. , “I'm very excited to connect ... experience and sports related interests to a program with a ...
(Date:11/22/2014)... Columbus, OH (PRWEB) November 22, 2014 ... trials for AndroGel side-effects lawsuits have been scheduled ... District Court, Northern District of Illinois. U.S. District Judge ... litigation, issued a Case Management Order (CMO) on November ... as deadlines for attorneys to submit documents and other ...
(Date:11/22/2014)... Steven Reinberg HealthDay Reporter ... outcomes are better when patients are treated in an ambulance ... drugs, German researchers report. The sooner patients get the ... the outcome after a stroke, the researchers noted. For the ... first hour after stroke symptoms start, the researchers said. ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3
... shows long-term weight control is achievable, Abstract 34, ... weight and want to keep it off might benefit ... Heart,Association,s Conference on Nutrition, Physical Activity and Metabolism., ... in the,Journal of the American Medical Association., In ...
... rates in follicular non-Hodgkin lymphoma , , THURSDAY, ... chemotherapy is safe and effective for patients ... an Italian study. , It found that ... ibritumombab tiuxetan, following chemotherapy with fludarabine and ...
... 13 Weight Watchers,International, Inc. (NYSE: WTW ) ... cash dividend of $0.175 per share, which corresponds,to an ... dividend will,be payable on April 11, 2008 to shareholders ... 2008., About Weight Watchers International, Inc., Weight ...
... on display, MINNEAPOLIS, March 13 This month, ... the free, professional,counseling from QUITPLAN(R) Services to successfully quit ... Capitol. The exhibits are on display,from Sunday, March 16 ... State,Capitol near the Rotunda., "The Capitol display is ...
... March 13 Setting the foundation for,continuing the ... Clinical Services (DCS) announced today that it doubled ... of outsourced,wound care, DCS will now have 20 ... regional senior vice presidents. With approximately 300,hospital partners ...
... Md., March 13 HHS, Agency for,Healthcare Research ... new health,information technology contracts that will focus on ... using clinical,decision support. Clinical decision support helps health ... and Women,s Hospital in Boston and Yale University ...
Cached Medicine News:Health News:American Heart Association Meeting Report 2Health News:American Heart Association Meeting Report 3Health News:American Heart Association Meeting Report 4Health News:American Heart Association Meeting Report 5Health News:American Heart Association Meeting Report 6Health News:American Heart Association Meeting Report 7Health News:American Heart Association Meeting Report 8Health News:American Heart Association Meeting Report 9Health News:American Heart Association Meeting Report 10Health News:American Heart Association Meeting Report 11Health News:American Heart Association Meeting Report 12Health News:American Heart Association Meeting Report 13Health News:Radioimmunotherapy After Chemo Safe for Common Lymphoma 2Health News:Weight Watchers Declares Quarterly Dividend 2Health News:ClearWay Minnesota(SM) Celebrates QUITPLAN(R) Services at the Capitol 2Health News:ClearWay Minnesota(SM) Celebrates QUITPLAN(R) Services at the Capitol 3Health News:Diversified Clinical Services Doubles Field Management 2Health News:AHRQ Awards $5 Million to Help Integrate Clinical Decision Support Technologies Into Health Care Delivery 2
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Passive heat and moisture exchangers for respiratory applications....
Passive heat and moisture exchangers for respiratory applications....
Medicine Products: